What is Rituximab?

Category: Prescription Drugs

Most popular types: Rituxan Mabthera

false

See also: DRC protocol FCMR protocol ILD Phase II/III Rituximab Versus Cyclophosphamide RECITAL Study R-CVP protocol RT protocol

Rituximab is a medication in a class of medications called monoclonal antibodies and given by infusion. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 103 72
Rheumatoid arthritis 81 43
Neuromyelitis optica 58 35
Systemic lupus erythematosus 18 8
Chronic lymphocytic leukemia 16 7
Follicular lymphoma 13 6

Show all 89 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 30
Moderate 34
Mild 69
None 78

Commonly reported side effects and conditions associated with Rituximab

Side effect Patients
Fatigue 29
Nausea 20
Headaches 10
Allergic reaction 7
Flu like symptoms 6
Facial flushing 4

Show all 122 reported side effects

Dosages

Based on patients currently taking Rituximab

Dosage Patients
10 mg every 6 months 13
1,000 mg every 6 months 10
10 mg every 3 months 3
2,000 mg every 6 months 3
10 mg yearly 2
10mg/mL as needed 2
4 g yearly 1
1 mcg every 8 weeks 1
10 mg every 12 weeks 1
10 mg every 6 weeks 1

See all 36 dosages

Why patients stopped taking Rituximab

Multiple reasons could be selected

Reason Patients
Course of treatment ended 55
Did not seem to work 36
Doctor's advice 28
Side effects too severe 24
Other 17
Change in health plan coverage 4
Expense 4
Personal research 3
See all 142 patients who've stopped taking Rituximab

Duration

Currently taking Rituximab

Duration Patients
Less than 1 month 1
1 - 6 months 7
6 months - 1 year 11
1 - 2 years 19
2 - 5 years 18
5 - 10 years 8
10 years or more 2

Stopped taking Rituximab

Duration Patients
Less than 1 month 56
1 - 6 months 31
6 months - 1 year 18
1 - 2 years 15
2 - 5 years 20
5 - 10 years 2
Adherence
Adherence Evaluations
Always 186
Usually 8
Sometimes 4
Never taken as prescribed 13
Burden
Burden Evaluations
Very hard to take 18
Somewhat hard to take 61
A little hard to take 70
Not at all hard to take 62
Cost per month
Cost per month Evaluations
$200+ 33
$100-199 12
$50-99 5
$25-49 4
< $25 61
Not specified 96

What people switch to and from

Patients started taking Rituximab after stopping:

Treatment Patients
Natalizumab (Tysabri) 11
Dimethyl fumarate (Tecfidera) 7
Methotrexate (Apo-Methotrexate) 6
Abatacept (Orencia) 5
Fingolimod (Gilenya) 5

Show all 34 treatments patients report switching from

Patients stopped taking Rituximab and switched to:

Treatment Patients
Ibrutinib (Imbruvica) 3
Natalizumab (Tysabri) 3
Tocilizumab (Actemra) 3
Dimethyl fumarate (Tecfidera) 2
Methotrexate (Apo-Methotrexate) 2

Show all 16 treatments patients report switching to

Last updated:

19 patient evaluations for Rituximab

Feb 15, 2017 (Started Jul 15, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: As needed

  • 0 helpful marks

Jan 29, 2017 (Started Jan 15, 2016)

  • Effectiveness
    Moderate (for non-Hodgkin's lymphoma)
  • Effectiveness
    Moderate (for follicular lymphoma)
  • Side effects
    Moderate (Fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 10 mg Weekly
Cost: < $25 monthly

  • 0 helpful marks

Sep 24, 2016 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: As needed
Advice & Tips: I had 2 infusions, 14 days apart. And that was it. The effect was not worth the price according to my rheumatologist (I paid nothing myself)
Cost: < $25 monthly

Jul 1, 2014 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 19 patient evaluations for Rituximab